MediPharm Labs Corp. (TSX: LABS)
Canada flag Canada · Delayed Price · Currency is CAD
0.0650
0.00 (0.00%)
Dec 20, 2024, 2:27 PM EST

MediPharm Labs Statistics

Total Valuation

MediPharm Labs has a market cap or net worth of CAD 26.72 million. The enterprise value is 13.95 million.

Market Cap 26.72M
Enterprise Value 13.95M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date Mar 28, 2025
Ex-Dividend Date n/a

Share Statistics

MediPharm Labs has 411.12 million shares outstanding. The number of shares has increased by 16.60% in one year.

Current Share Class n/a
Shares Outstanding 411.12M
Shares Change (YoY) +16.60%
Shares Change (QoQ) +1.55%
Owned by Insiders (%) 7.79%
Owned by Institutions (%) 0.71%
Float 379.07M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.66
PB Ratio 0.59
P/TBV Ratio 0.61
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.19
EV / Sales 0.36
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -5.47

Financial Position

The company has a current ratio of 3.21, with a Debt / Equity ratio of 0.01.

Current Ratio 3.21
Quick Ratio 1.87
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF -0.26
Interest Coverage -8.80

Financial Efficiency

Return on equity (ROE) is -23.45% and return on invested capital (ROIC) is -6.96%.

Return on Equity (ROE) -23.45%
Return on Assets (ROA) -5.83%
Return on Capital (ROIC) -6.96%
Revenue Per Employee 235,241
Profits Per Employee -70,813
Employee Count 166
Asset Turnover 0.63
Inventory Turnover 2.63

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +8.33% in the last 52 weeks. The beta is 0.88, so MediPharm Labs's price volatility has been lower than the market average.

Beta (5Y) 0.88
52-Week Price Change +8.33%
50-Day Moving Average 0.07
200-Day Moving Average 0.07
Relative Strength Index (RSI) 48.28
Average Volume (20 Days) 222,239

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, MediPharm Labs had revenue of CAD 39.05 million and -11.76 million in losses. Loss per share was -0.03.

Revenue 39.05M
Gross Profit 13.71M
Operating Income -5.77M
Pretax Income -12.03M
Net Income -11.76M
EBITDA -3.17M
EBIT -5.77M
Loss Per Share -0.03
Full Income Statement

Balance Sheet

The company has 13.43 million in cash and 654,000 in debt, giving a net cash position of 12.78 million or 0.03 per share.

Cash & Cash Equivalents 13.43M
Total Debt 654,000
Net Cash 12.78M
Net Cash Per Share 0.03
Equity (Book Value) 45.05M
Book Value Per Share 0.11
Working Capital 23.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.32 million and capital expenditures -229,000, giving a free cash flow of -2.55 million.

Operating Cash Flow -2.32M
Capital Expenditures -229,000
Free Cash Flow -2.55M
FCF Per Share -0.01
Full Cash Flow Statement

Margins

Gross margin is 35.10%, with operating and profit margins of -14.78% and -30.10%.

Gross Margin 35.10%
Operating Margin -14.78%
Pretax Margin -30.80%
Profit Margin -30.10%
EBITDA Margin -8.13%
EBIT Margin -14.78%
FCF Margin n/a

Dividends & Yields

MediPharm Labs does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -16.60%
Shareholder Yield -16.60%
Earnings Yield -45.27%
FCF Yield -9.54%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MediPharm Labs has an Altman Z-Score of -2.18. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.18
Piotroski F-Score n/a